Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Oratz

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Breast Cancer Research and Treatment|January 5, 2023
Early effectiveness and toxicity outcomes of reirradiation after breast conserving surgery for recurrent or new primary breast cancerCamille Hardy-Abeloos, Julie Xiao, Cheongeun Oh, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2009
Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumorsAnna C Pavlick, Jennifer Wu, John Roberts, et al.
Journal for Immunotherapy of Cancer|April 5, 2025
Topical TLR7 agonist and radiotherapy in patients with metastatic breast cancerSylvia Adams, Sandra Demaria, Darawan Rinchai, et al.
Journal of Cancer Research and Clinical Oncology|October 3, 2025
Evaluation of the gut microbiome and sex hormones in postmenopausal women with newly diagnosed hormone receptor-positive breast cancer versus healthy women: a prospective case-control studyMaryann Kwa, Grant Hussey, Yelena Novik, et al.
Breast Cancer Research and Treatment|November 11, 2017
Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancerMaryann Kwa, Xiaochun Li, Yelena Novik, et al.
Human Genetics|January 29, 2013
Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutationErica S Rinella, Yongzhao Shao, Lauren Yackowski, et al.
Neurosurgery|August 15, 2023
Long-term Survival From Breast Cancer Brain Metastases in the Era of Modern Systemic TherapiesElad Mashiach, Juan Diego Alzate, Fernando De Nigris Vasconcellos, et al.
Journal of Neuro-Oncology|April 17, 2024
Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approachesElad Mashiach, Juan Diego Alzate, Fernando De Nigris Vasconcellos, et al.
The Oncologist|May 31, 2022
Outcomes of Breast Cancer Patients Treated with Chemotherapy, Biologic Therapy, Endocrine Therapy, or Active Surveillance During the COVID-19 PandemicDouglas K Marks, Nibash Budhathoki, John Kucharczyk, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Breast Cancer Research and Treatment|January 5, 2023
Early effectiveness and toxicity outcomes of reirradiation after breast conserving surgery for recurrent or new primary breast cancerCamille Hardy-Abeloos, Julie Xiao, Cheongeun Oh, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2009
Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumorsAnna C Pavlick, Jennifer Wu, John Roberts, et al.
Journal for Immunotherapy of Cancer|April 5, 2025
Topical TLR7 agonist and radiotherapy in patients with metastatic breast cancerSylvia Adams, Sandra Demaria, Darawan Rinchai, et al.
Journal of Cancer Research and Clinical Oncology|October 3, 2025
Evaluation of the gut microbiome and sex hormones in postmenopausal women with newly diagnosed hormone receptor-positive breast cancer versus healthy women: a prospective case-control studyMaryann Kwa, Grant Hussey, Yelena Novik, et al.
Breast Cancer Research and Treatment|November 11, 2017
Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancerMaryann Kwa, Xiaochun Li, Yelena Novik, et al.
Human Genetics|January 29, 2013
Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutationErica S Rinella, Yongzhao Shao, Lauren Yackowski, et al.
Neurosurgery|August 15, 2023
Long-term Survival From Breast Cancer Brain Metastases in the Era of Modern Systemic TherapiesElad Mashiach, Juan Diego Alzate, Fernando De Nigris Vasconcellos, et al.
Journal of Neuro-Oncology|April 17, 2024
Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approachesElad Mashiach, Juan Diego Alzate, Fernando De Nigris Vasconcellos, et al.
The Oncologist|May 31, 2022
Outcomes of Breast Cancer Patients Treated with Chemotherapy, Biologic Therapy, Endocrine Therapy, or Active Surveillance During the COVID-19 PandemicDouglas K Marks, Nibash Budhathoki, John Kucharczyk, et al.
Pageof 3